Scalp psoriasis treatment approved for teens

| Melissa Leavitt

For the first time, teens with scalp psoriasis have a treatment made just for them.

Taclonex, a topical medication, received Food and Drug Administration (FDA) approval for the treatment of scalp psoriasis in adolescents aged 12 to 17 years old, according to a statement released by LEO Pharma, Taclonex’s manufacturer. The drug is to be used once daily for up to eight weeks, as noted in the statement.

Taclonex, which combines a topical steroid with calcipotriene, a vitamin D analog, had already been approved to treat scalp and body psoriasis in adults. With this new indication, it becomes the first FDA-approved treatment for scalp psoriasis in teenagers on the market, according to the statement.

Because Taclonex is only applied once a day, it could be especially effective in teenagers, who do not always follow more complex treatment directions, said Kelly Cordoro, an associate professor of Dermatology and Pediatrics at the University of California, San Francisco, as quoted in the statement.

Scalp involvement is a common feature of psoriatic disease in children and teenagers.


Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Capitol hill, advocacy, legislation
We will continue to advocate for better health care for psoriatic disease...
LITE study logo
A new clinical trial researching the effectiveness and safety of home-based...
cartoon of people studying giant book
NPF and the American College of Rheumatology release a pioneering treatment...
Psoriatic disease patient Ellen Clements
Ellen Clements overcomes flares, joint pain and bullies in the office to...
Michael Bentley on his radio
A Texas man finds the right specialists and gets approved for disability...
Leah McCormick Howard and Stephen Katz
Longtime NIAMS director was a friend to all he served.
cartoon two scientists with giant microscope and helix in background
You don’t need an advanced degree in biochemistry to be a Citizen Pscientist,...
Edgar Payano, psoriasis, Dominican
A Dominican-American man with psoriasis fends off the usual annoying questions...
NPF, Tide, Seal of Recognition, Proctor & Gamble
NPF awards Seal of Recognition to two Procter & Gamble Tide products.